|
1
|
Fincham AG, Belcourt AB, Termine JD,
Butler WT and Cothran WC: Amelogenins. Sequence homologies in
enamel-matrix proteins from three mammalian species. Biochem J.
211:149–154. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miron RJ, Caluseru OM, Guillemette V,
Zhang Y, Gemperli AC, Chandad F and Sculean A: Influence of enamel
matrix derivative on cells at different maturation stages of
differentiation. PLoS One. 8:e710082013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miron RJ, Wei L, Yang S, Caluseru OM,
Sculean A and Zhang Y: Effect of enamel matrix derivative on
periodontal wound healing and regeneration in an osteoporotic
model. J Periodontol. 85:1603–1611. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fincham AG, Belcourt AB, Termine JD,
Butler WT and Cothran WC: Dental enamel matrix: Sequences of two
amelogenin polypeptides. Biosci Rep. 1:771–778. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fincham AG, Hu YY, Pavlova Z, Slavkin HC
and Snead ML: Human amelogenins: Sequences of ‘TRAP’ molecules.
Calcif Tissue Int. 45:243–250. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grayson RE, Yamakoshi Y, Wood EJ and Agren
MS: The effect of the amelogenin fraction of enamel matrix proteins
on fibroblast-mediated collagen matrix reorganization.
Biomaterials. 27:2926–2933. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hoang AM, Klebe RJ, Steffensen B, Ryu OH,
Simmer JP and Cochran DL: Amelogenin is a cell adhesion protein. J
Dent Res. 81:497–500. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsuzawa M, Sheu TJ, Lee YJ, Chen M, Li
TF, Huang CT, Holz JD and Puzas JE: Putative signaling action of
amelogenin utilizes the Wnt/beta-catenin pathway. J Periodontal
Res. 44:289–296. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun Z, Fan D, Fan Y, Du C and
Moradian-Oldak J: Enamel proteases reduce amelogenin-apatite
binding. J Dent Res. 87:1133–1137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tan J, Leung W, Moradian-Oldak J,
Zeichner-David M and Fincham AG: Quantitative analysis of
amelogenin solubility. J Dent Res. 77:1388–1396. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamakoshi Y: Porcine Amelogenin:
Alternative splicing, proteolytic processing, protein-protein
interactions, and possible functions. J Oral Biosci. 53:275–283.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kawase T, Okuda K, Momose M, Kato Y,
Yoshie H and Burns DM: Enamel matrix derivative (EMDOGAIN) rapidly
stimulates phosphorylation of the MAP kinase family and nuclear
accumulation of smad2 in both oral epithelial and fibroblastic
human cells. J Periodontal Res. 36:367–376. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kawase T, Okuda K, Yoshie H and Burns DM:
Cytostatic action of enamel matrix derivative (EMDOGAIN) on human
oral squamous cell carcinoma-derived SCC25 epithelial cells. J
Periodontal Res. 35:291–300. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawase T, Okuda K, Yoshie H and Burns DM:
Anti-TGF-beta antibody blocks enamel matrix derivative-induced
upregulation of p21WAF1/cip1 and prevents its inhibition of human
oral epithelial cell proliferation. J Periodontal Res. 37:255–262.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lyngstadaas SP, Lundberg E, Ekdahl H,
Andersson C and Gestrelius S: Autocrine growth factors in human
periodontal ligament cells cultured on enamel matrix derivative. J
Clin Periodontol. 28:181–188. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gestrelius S, Andersson C, Lidström D,
Hammarström L and Somerman M: In vitro studies on periodontal
ligament cells and enamel matrix derivative. J Clin Periodontol.
24:685–692. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mirastschijski U, Konrad D, Lundberg E,
Lyngstadaas SP, Jorgensen LN and Agren MS: Effects of a topical
enamel matrix derivative on skin wound healing. Wound Repair Regen.
12:100–108. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Shu R, Liu D and Jiang S: Different
effects of 25-kDa amelogenin on the proliferation, attachment and
migration of various periodontal cells. Biochem Biophys Res Commun.
394:581–586. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li XT, Shu R, Song ZC and Zhou YB: The
effects of recombinant porcine amelogenin on human gingival
epithelial cells. Shanghai Kou Qiang Yi Xue. 21:257–261. 2012.(In
Chinese). PubMed/NCBI
|
|
20
|
Sambrook J and Russel DW: Molecular
cloning a laboratory manual. Cold Spring Harbor Laboratory Press;
New Yourk: Cold Spring Harbor Laboratory Press. 2001
|
|
21
|
Amin HD, Olsen I, Knowles JC and Donos N:
Differential effect of amelogenin peptides on osteogenic
differentiation in vitro: Identification of possible new drugs for
bone repair and regeneration. Tissue Eng Part A. 18:1193–1202.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Frasheri I, Ern C, Diegritz C, Hickel R,
Hristov M and Folwaczny M: Full-length amelogenin influences the
differentiation of human dental pulp stem cells. Stem Cell Res
Ther. 7:102016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Amin HD, Olsen I, Knowles J, Dard M and
Donos N: A tyrosine-rich amelogenin peptide promotes
neovasculogenesis in vitro and ex vivo. Acta Biomater.
10:1930–1939. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grandin HM, Gemperli AC and Dard M: Enamel
matrix derivative: A review of cellular effects in vitro and a
model of molecular arrangement and functioning. Tissue Eng Part B
Rev. 18:181–202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xi B, Yu N, Wang X, Xu X and Abassi YA:
The application of cell-based label-free technology in drug
discovery. Biotechnol J. 3:484–495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sanz M, Tonetti MS, Zabalegui I, Sicilia
A, Blanco J, Rebelo H, Rasperini G, Merli M, Cortellini P and Suvan
JE: Treatment of intrabony defects with enamel matrix proteins or
barrier membranes: Results from a multicenter practice-based
clinical trial. J Periodontol. 75:726–733. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Laaksonen M, Sorsa T and Salo T: Emdogain
in carcinogenesis: A systematic review of in vitro studies. J Oral
Sci. 52:1–11. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Villa O, Wohlfahrt JC, Mdla I, Petzold C,
Reseland JE, Snead ML and Lyngstadaas SP: Proline-rich peptide
mimics effects of enamel matrix derivative on rat oral mucosa
incisional wound healing. J Periodontol. 86:1386–1395. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maymon-Gil T, Weinberg E, Nemcovsky C and
Weinreb M: Enamel matrix derivative promotes healing of a surgical
wound in the rat oral mucosa. J Periodontol. 87:601–609. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Laaksonen M, Suojanen J, Nurmenniemi S,
Läärä E, Sorsa T and Salo T: The enamel matrix derivative
(Emdogain) enhances human tongue carcinoma cells gelatinase
production, migration and metastasis formation. Oral Oncol.
44:733–742. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schwartz Z, Carnes DL Jr, Pulliam R,
Lohmann CH, Sylvia VL, Liu Y, Dean DD, Cochran DL and Boyan BD:
Porcine fetal enamel matrix derivative stimulates proliferation but
not differentiation of pre-osteoblastic 2T9 cells, inhibits
proliferation and stimulates differentiation of osteoblast-like
MG63 cells, and increases proliferation and differentiation of
normal human osteoblast NHOst cells. J Periodontol. 71:1287–1296.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shimizu-Ishiura M, Tanaka S, Lee WS,
Debari K and Sasaki T: Effects of enamel matrix derivative to
titanium implantation in rat femurs. J Biomed Mater Res.
60:269–276. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang YC, Tanimoto K, Tanne Y, Kamiya T,
Kunimatsu R, Michida M, Yoshioka M, Yoshimi Y, Kato Y and Tanne K:
Effects of human full-length amelogenin on the proliferation of
human mesenchymal stem cells derived from bone marrow. Cell Tissue
Res. 342:205–212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hatakeyama J, Philp D, Hatakeyama Y,
Haruyama N, Shum L, Aragon MA, Yuan Z, Gibson CW, Sreenath T,
Kleinman HK and Kulkarni AB: Amelogenin-mediated regulation of
osteoclastogenesis, and periodontal cell proliferation and
migration. J Dent Res. 85:144–149. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kuramitsu-Fujimoto S, Ariyoshi W, Saito N,
Okinaga T, Kamo M, Ishisaki A, Takata T, Yamaguchi K and Nishihara
T: Novel biological activity of ameloblastin in enamel matrix
derivative. J Appl Oral Sci. 23:49–55. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hatakeyama J, Fukumoto S, Nakamura T,
Haruyama N, Suzuki S, Hatakeyama Y, Shum L, Gibson CW, Yamada Y and
Kulkarni AB: Synergistic roles of amelogenin and ameloblastin. J
Dent Res. 88:318–322. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jonke E, Gemperli AC, Zhang T, Özdemir B,
Dard M, Rausch-Fan X and Andrukhov O: Effect of tyrosine-rich
amelogenin peptide on behavior and differentiation of endothelial
cells. Clin Oral Investig. Feb 12–2016.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ravindranath RM, Tam WY, Nguyen P and
Fincham AG: The enamel protein amelogenin binds to the
N-acetyl-D-glucosamine-mimicking peptide motif of cytokeratins. J
Biol Chem. 275:39654–39661. 2000. View Article : Google Scholar : PubMed/NCBI
|
